Graig Suvannavejh

Stock Analyst at Mizuho

(0)
# 4469
Out of 5,329 analysts
172
Total ratings
34.12%
Success rate
-14.94%
Average return
45 Stocks
Name Action PT Current % Upside Ratings Updated
IMCR Immunocore Holdings
Maintains: Neutral
38 33
30.41 8.52% 8 Apr 7, 2025
AMLX Amylyx Pharmaceutica...
Upgrades: Outperform
3 7
5.24 33.59% 6 Apr 7, 2025
AXSM Axsome Therapeutics
Maintains: Outperform
212 216
113.17 90.86% 21 Mar 27, 2025
HRMY Harmony Biosciences ...
Maintains: Outperform
42 44
29.88 47.26% 17 Mar 18, 2025
ITCI Intra-Cellular Thera...
Downgrades: Neutral
140 132
n/a n/a 10 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
3 2
0.28 435.71% 2 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7 8
1.4 442.86% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
39 38
20.3 87.19% 6 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 74
7.64 868.59% 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5 1
0.29 72.41% 3 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
44 49
61.58 -20.43% 6 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
21.03 137.76% 1 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
0.78 2464.1% 1 Jul 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
36 82
73.09 12.19% 6 Jun 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
14 16
5.18 208.88% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
39 30
7.22 315.51% 4 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 22
3.53 523.23% 4 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 8
1.29 520.16% 1 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 4
3.61 -3.05% 1 Mar 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
25 45
n/a n/a 9 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 10
3.58 179.33% 5 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 9
1.25 620% 4 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
64
1.85 3359.46% 8 Aug 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
274 258
n/a n/a 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 1
4.49 -77.73% 5 Jun 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
2.56 485.94% 1 Mar 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 35
64.63 -45.85% 5 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
9 8
4.77 67.71% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
71 57
37.31 52.77% 2 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
8 5
45.59 -89.03% 4 Apr 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
n/a n/a 2 Oct 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
8 6
n/a n/a 2 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
53
n/a n/a 1 Jul 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
6.28 441.4% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
28
4.89 472.6% 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
31
16.86 83.87% 1 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
19
0.68 2694.12% 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
5
2.21 114.93% 1 Nov 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
36
15.03 139.52% 2 Nov 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 1 Oct 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
37
0.92 3921.74% 1 Oct 20, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
128
119.75 6.89% 1 Sep 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 10
n/a n/a 1 Aug 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
29
n/a n/a 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
35
n/a n/a 1 Jan 8, 2020